K. Madsen

发表

Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness.

L. B. Knudsen, K. Madsen, H. Agersoe, 2007, Journal of medicinal chemistry.

Erratum: Does gut hormone PVY3-36 decrease food intake in rodents? (Nature (2004) 430 (165) DOI:10.1038/nature03019)

D. Allison, R. Seeley, M. Tschöp, 2004 .

Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.

T. Kruse, H. Strauss, S. M. Knudsen, 2015, Journal of medicinal chemistry.

Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.

R. Rudolph, S. M. Knudsen, K. Madsen, 2007, Biochemistry.

Ipamorelin, the first selective growth hormone secretagogue.

K. Raun, K. Madsen, H. Thøgersen, 1998, European journal of endocrinology.

Physiology: Does gut hormone PYY3–36 decrease food intake in rodents?

D. Allison, R. Seeley, M. Tschöp, 2004, Nature.

The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Activation of Central Neuropeptide Y Y1 Receptors Potently Stimulates Food Intake in Male Rhesus Monkeys*

P. J. Larsen, J. Cameron, M. Smith, 1999 .

PYY3‐36 as an anti‐obesity drug target

D. Allison, R. Seeley, M. Tschöp, 2005, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Ketomethylene and (cyanomethylene)amino pseudopeptide analogues of the C-terminal hexapeptide of neurotensin.

P. Suzdak, I. Gomez-Monterrey, M. García-López, 1995, Journal of medicinal chemistry.

Structure-function analysis of human CYP3A4 using a specific proinhibitory antipeptide antibody.

R. Bywater, K. Madsen, T. Schulz-utermoehl, 2000, Drug metabolism and disposition: the biological fate of chemicals.

OF HUMAN CYP 3 A 4 USING A SPECIFIC PROINHIBITORY ANTIPEPTIDE ANTIBODY

R. Bywater, K. Madsen, T. Schulz-utermoehl, 2000 .

Appetite Regulatory Peptides PYY 3-36 as an anti-obesity drug target

D. Allison, R. Seeley, M. Tschöp, 2005 .

Regulation of nuclear scaffold protease activity by calcium.

G. Fiskum, G. Clawson, K. Madsen, 1990, Experimental cell research.

Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.

L. B. Knudsen, K. Madsen, P. F. Nielsen, 2000, Journal of medicinal chemistry.

Three Distinct Epitopes on the Extracellular Face of the Glucagon Receptor Determine Specificity for the Glucagon Amino Terminus*

B. Wulff, L. B. Knudsen, K. Madsen, 2003, Journal of Biological Chemistry.

Implications of replacing peptide bonds in the COOH-terminal B chain domain of insulin by the psi (CH2-NH) linker.

T. Schwartz, K. Madsen, N. L. Johansen, 2009, International journal of peptide and protein research.

A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.

K. Raun, K. Madsen, H. Thøgersen, 1998, Journal of medicinal chemistry.

Aminomethylthiophene‐2‐carboxylic Acids as Dipeptide Mimetic in New Growth Hormone Secretagogues.

K. Madsen, N. L. Johansen, B. S. Hansen, 1997 .

Important role of C-terminal peptide bonds for endothelin receptor binding and activity.

P. Suzdak, J. Weis, K. Madsen, 1993, Pharmacology & toxicology.

Aminomethylthiophene-2-carboxylic acids as dipeptide mimetic in new growth hormone secretagogues

K. Madsen, N. L. Johansen, B. S. Hansen, 1997 .

Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular Domain*

Kjeld Madsen, R. Rudolph, K. Madsen, 2008, Journal of Biological Chemistry.

Different domains of the glucagon and glucagon‐like peptide‐1 receptors provide the critical determinants of ligand selectivity

B. Wulff, L. B. Knudsen, K. Madsen, 2003, British journal of pharmacology.

C-Terminally PEGylated hGH-derivatives.

M. Zundel, K. Madsen, Anja K Pedersen, 2007, Bioorganic & medicinal chemistry.

Constrained C-terminal hexapeptide neurotensin analogues containing a 3-oxoindolizidine skeleton

P. Suzdak, M. García-López, R. González-Muñiz, 1995, Letters in Peptide Science.

Structure-activity relationships of endothelin analogs

P. Suzdak, K. Madsen, H. Thøgersen, 1991 .

Superiority of sandwich ELISA over competitive RIA for the estimation of ANP-270, an analogue of human atrial natriuretic factor.

S. Ingwersen, H. Eiskjaer, K. Madsen, 1992, Journal of immunological methods.

[3H]ac-RYYRWK-NH2, a novel specific radioligand for the nociceptin/orphanin FQ receptor

C. Foged, K. Madsen, N. L. Johansen, 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity

J. Holst, C. Deacon, L. B. Knudsen, 1998, Diabetologia.

Highly active atrial natriuretic factor (ANF) analogues, lacking the exocyclic N- and C-termini

K. Madsen, H. Thøgersen, N. L. Johansen, 1994 .

14C-labelling of ipamorelin, a growth hormone secretagogue

C. Foged, K. Madsen, L. Müller, 1998 .